Factors Influencing Plasma Concentrations of Ethosuximide

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Clinical Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2165/00003088-197904010-00004PMID 421410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors influencing plasma phenobarbitone levels in epileptic patients.

  1977cited by this paper
• Ethosuximide dosage regimens

  1976cited by this paper
• Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

  1976cited by this paper
• Clinical Pharmacokinetics of β-Adrenoceptor Blocking Drugs

  1976cited by this paper
• Ethosuximide in the treatment of absence (petit mal) seizures

  1975cited by this paper
• Relative Frequency of Different Types of Epilepsy: A Study Employing the Classification of the International League Against Epilepsy

  1975cited by this paper
• The absorption and excretion of ethosuximide.

  1973cited by this paper
• The simultaneous determination of multiple anticonvulsant drug levels by gas‐liquid chromatography

  1972cited by this paper
• Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

  1972cited by this paper
• Ethosuximide blood levels in epileptics.

  1970cited by this paper

• Model‐Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy

  2023cites this paper
• Therapeutic Options for Childhood Absence Epilepsy

  2021cites this paper
• Pharmacokinetic considerations about antiseizure medications in the elderly

  2020cites this paper
• A Practical Guide to Treatment of Childhood Absence Epilepsy

  2019cites this paper
• Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1.

  2017cites this paper
• Perampanel Serum Concentrations in Adults With Epilepsy: Effect of Dose, Age, Sex, and Concomitant Anti-Epileptic Drugs

  2016cites this paper
• Perampanel serum concentrations in adults with epilepsy: Effect of dose, age, gender and concomitant antiepileptic drugs

  2015cites this paper
• Gender issues in antiepileptic drug treatment.

  2014cites this paper
• Older Anticonvulsants Continuing in Use but with Limited Advance in Knowledge

  1999cites this paper
• Pharmacokinetic Interactions Between Antiepileptic Drugs

  1996cites this paper
• Clinical Pharmacokinetics of Antiepileptic Drugs in Paediatric Patients

  1995cites this paper
• Drug Treatment of Epilepsy

  1987cites this paper
• Monitoring Antiepileptic Drug Levels

  1985cites this paper
• Clinical Pharmacokinetics of Antiepileptic Drugs

  1985cites this paper
• Valproic Acid‐Ethosuximide Interaction: A Pharmacokinetic Study

  1984cites this paper
• Anticonvulsant Drugs

  1984cites this paper
• Antiepileptika: Grundlagen und Therapie

  1983cites this paper
• Ethosuximide kinetics: Possible interaction with valproic acid

  1982cites this paper
• Ethosuximide Plasma Concentrations: Influence of Age and Associated Concomitant Therapy

  1982cites this paper
• Hemodialysis clearance of ethosuximide in patients with chronic renal disease.

  1981cites this paper
• Therapeutics bibliography for clinical pharmacists: neurology.

  1980cites this paper
• Pharmacokinetics and therapeutics in epilepsy

  1979cites this paper